HUMAN PROGELATINASE-A CAN BE ACTIVATED BY AUTOLYSIS AT A RATE THAT IS CONCENTRATION-DEPENDENT AND ENHANCED BY HEPARIN BOUND TO THE C-TERMINAL DOMAIN

被引:84
作者
CRABBE, T
IOANNOU, C
DOCHERTY, AJP
机构
[1] Department of Oncology Biology, Celltech Research, Slough
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1993年 / 218卷 / 02期
关键词
D O I
10.1111/j.1432-1033.1993.tb18393.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation of the latent precursor of human gelatinase A (progelatinase A) was investigated using recombinant proenzyme purified from culture medium conditioned by transfected mouse myeloma cells. A 4.0 muM progelatinase A solution was activated to a maximum of 48% of the activity produced by 4-aminophenylmercuric acetate (APMA) simply by its incubation at 37-degrees-C for 12 h, though at lower starting concentrations the rate and extent of activation were reduced. Activation was shown to be the result of a single autolytic cleavage at the Asn80-Tyr81 peptide bond that removes the propeptide and converts the M(r) = 72000 proenzyme into the M(r) = 66000 active species also produced by APMA activation. It is proposed that this cleavage is a bimolecular event catalysed by previously activated gelatinase A. The addition of heparin increased by approximately eightfold the initial rate of progelatinase A autolytic activation but did not affect the activation of a deletion mutant that lacked the C-terminal domain [des-(418-631)progelatinase A]. The inference that this increase resulted from an interaction between heparin and the C-terminal domain was supported by the finding that, unlike des-(418-631)gelatinase A, both full-length gelatinase A and the isolated C-terminal domain were able to bind to heparin-Sepharose CL-6B and that, at NaCl concentrations sufficient to abolish this binding, heparin had no effect. We conclude that heparin is able to enhance autolytic activation by acting as a template that approximates active --> latent gelatinase A and suggest that a similar mechanism may account for the cell-surface activation of this enzyme.
引用
收藏
页码:431 / 438
页数:8
相关论文
共 49 条
  • [1] AZZAM HS, 1992, CANCER RES, V52, P4540
  • [2] MONOCLONAL-ANTIBODIES TO HUMAN FIBROBLAST PROCOLLAGENASE - INHIBITION OF ENZYMATIC-ACTIVITY, AFFINITY PURIFICATION OF THE ENZYME, AND EVIDENCE FOR CLUSTERING OF EPITOPES IN THE NH2-TERMINAL END OF THE ACTIVATED ENZYME
    BIRKEDALHANSEN, B
    MOORE, WGI
    TAYLOR, RE
    BHOWN, AS
    BIRKEDALHANSEN, H
    [J]. BIOCHEMISTRY, 1988, 27 (18) : 6751 - 6758
  • [3] BROWN PD, 1990, CANCER RES, V50, P6184
  • [4] MOLECULAR MODELING OF PROTEIN-GLYCOSAMINOGLYCAN INTERACTIONS
    CARDIN, AD
    WEINTRAUB, HJR
    [J]. ARTERIOSCLEROSIS, 1989, 9 (01): : 21 - 32
  • [5] COLLIER IE, 1988, J BIOL CHEM, V263, P6579
  • [6] BIOCHEMICAL-CHARACTERIZATION OF MATRILYSIN - ACTIVATION CONFORMS TO THE STEPWISE MECHANISMS PROPOSED FOR OTHER MATRIX METALLOPROTEINASES
    CRABBE, T
    WILLENBROCK, F
    EATON, D
    HYNDS, P
    CARNE, AF
    MURPHY, G
    DOCHERTY, AJP
    [J]. BIOCHEMISTRY, 1992, 31 (36) : 8500 - 8507
  • [7] DANIELSSON A, 1986, J BIOL CHEM, V261
  • [8] DAVIS GE, 1990, CANCER RES, V50, P1113
  • [9] THE MATRIX METALLOPROTEINASES AND THEIR NATURAL INHIBITORS - PROSPECTS FOR TREATING DEGENERATIVE TISSUE-DISEASES
    DOCHERTY, AJP
    OCONNELL, J
    CRABBE, T
    ANGAL, S
    MURPHY, G
    [J]. TRENDS IN BIOTECHNOLOGY, 1992, 10 (06) : 200 - 207
  • [10] EMONARD HP, 1992, CANCER RES, V52, P5845